U.S News

J&J Vaccine Reapproved After Review Of ‘Extremely Rare’ Blood Clots

j&j-vaccine-reapproved-after-review-of-‘extremely-rare’-blood-clots

A rare side effect, seen by 1.9 people per million doses given, forced the CDC and FDA to pause distribution of the COVID-19 vaccine last week.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:U.S News